Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study.
Impact of Disease-Modifying Therapies on the Survival of Patients with Multiple Sclerosis in Taiwan, 1997-2008.
MicroRNAs: The Role in Autoimmune Inflammation.
Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.
In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade.
Effect of vitamin D on MS activity by disease-modifying therapy class.
Clarity Extension Study
Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.
Epigenetics of Multiple Sclerosis: An Updated Review.
Long-term Impact of Early MS Treatment with Interferon Beta-1b (IFNB-1b): Clinical, MRI, Employment, and Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11)
Bilateral optic neuritis in a patient with Behçet's disease who respond to therapeutic plasma exchange.
Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.
Individual Neuronal Subtypes Exhibit Diversity in CNS Myelination Mediated by Synaptic Vesicle Release.
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.
Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 response.
Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study.
Prevalence of Multiple Sclerosis in the Republic of Moldova.
Fatigue and Comorbidities in Multiple Sclerosis.
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
[Th17-mediated relapsing-remitting multiple sclerosis is nonresponsive to interferon-β1b].
Autoimmune sleep disorders.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of Brain- Part 2.

Pages